Oct 30 2011
|more articles from|
Announcement of New Therapy Programs made at Third Anniversary Celebrations of The City Hospital
Dubai, UAE, 30 October 2011: The City Hospital , owned and operated by EHL Management Services, marked its Third Anniversary with a ceremony attended by Chairperson of Dubai Healthcare City Authority HRH Princess Haya Bint Al Hussein, wife of HH Sheikh Mohammed Bin Rashid Al Maktoum, Vice-President and Prime Minister of the UAE and Ruler of Dubai. The hospital marked the occasion with the announcement of two new services, in partnership with Prima BioMed, which will reform the treatment of ovarian cancer and blood-related disorders in the UAE.
The CVac™ therapy program is new to the Middle East and will be available for the first time at The City Hospital . Cvac uses the patient's own immune cells that are collected in the hospital and prepares them to attack a cancer protein called mucin 1. Mucin 1 is expressed on ovarian cancer cells as well as numerous other cancer types. When the treated patient cells are injected back into the body, they start a chain reaction that results in the body's own immune killer cells targeting and killing the cancer mucin 1-expressing cells and tissue. This treatment will bring forward the fight against a disease which is the fifth largest cause of cancer deaths among women globally and which kills seven out of 10 sufferers in less than five years. Dr. Fadi Mikhael , who will lead the program at The City Hospital said: "The approval for the provision of CVac™ by The City Hospital , in partnership with Prima Biomed, is a huge milestone for cancer care not only in Dubai but the region as a whole. This treatment offers hope to thousands of women living in the Middle East who are suffering from ovarian cancer. We hope in time to be able to extend the application of CVac™ to other mucin-1 positive tumours - and treat other types of cancer."
The City Hospital also announced the launch of its Therapeutic Apheresis Unit, in conjunction with Prima Biomed. Therapeutic apheresis is a general term for treatments that remove harmful proteins, chemicals or cells in the blood that contribute to disease. Similar to the apheresis blood donation process, an automated machine separates blood components, isolates the targeted substance and returns the remaining components to the patient. This is the first time this service has been offered in Dubai. Dr. Musa Mbahi, Specialist Anatomical and Clinical Pathologist and Fellow of Blood Banking and Transfusion from the renowned MD Anderson Cancer Centre in the USA will lead the unit. He commented: "Therapeutic Apheresis can radically transform the lives of people suffering from blood disorders, kidney problems, metabolic diseases, neurological disorders and autoimmune conditions. Now, for the first time in Dubai, patients can benefit from effects of this treatment and I am proud to be leading the unit at The City Hospital ."
The City Hospital is a 210-bed, state-of-the-art, fully equipped, multi-disciplinary modern hospital which facilitates world-class healthcare and hospitality. It can accommodate patients with a vast range of different medical needs. It offers specialised treatment in the areas of cardiology, radiology, gynaecology, trauma, endocrinology amongst many others.
About EHL Management Services
EHL Management Services (formerly Welcare World) is the healthcare management company of the Emirates Healthcare Group - a joint venture between the South African private hospital group MediClinic International, the Dubai-based Varkey Group and General Electric (GE) Healthcare. MediClinic International manages 52 hospitals in South Africa, 3 in Namibia and owns Hirslanden AG, the leading private hospital group in Switzerland, with 14 hospitals.
EHL Management Services has combined strategic international alliances with in-house expertise to become one of the leading healthcare providers in the UAE comprising of ten world-class medical facilities that offer complete medicare services in the Middle East region.
Facilities in Dubai include The City Hospital , Welcare Hospital, Welcare Clinic Mirdif, Welcare Clinic Al Qusais, EHL Meadows Clinic, Emirates Diagnostic Clinic, Welcare Ambulatory Care Centre, EHL Arabian Ranches Clinic, Welcare Clinic Ibn Battuta and EHL Dubai Mall Medical Centre. For further information about EHL and its facilities visit www.ehl.ae.
About Prima BioMed
Prima BioMed is an ASX listed Australian health care company. The Company is focused on technologies in the fields of cancer immunotherapy and immunology. Prima's lead product is CVac™. The Company's broader, long term goal is to develop additional commercial cancer treatment technologies and programs for global markets. Further information can be found at: www.primabiomed.com.au
For further information, please contact:
EHL Management Services
Tel: + 97144495285
© Press Release 2011
© Copyright Zawya. All Rights Reserved.
People Who Read This Also Read
- Beetles, housefly larvae open new frontier in animal feed sector
- N.Korean leader Kim used luxury yacht to tour coast -website
- NASA wants backyard astronomers to help track asteroids
- CORRECTED-Kimberly-Clark moves to ease Venezuelan toilet paper shortage
- CORRECTED-U.S. patent case climaxes with win for Canadian vibrator maker
- There's More